| EBCCP Program Areas | Behavioral and/or Psychosocial Outcomes | Cognitive Change Outcomes (i.e., changes in: knowledge, risk perception, decisional satisfaction) |
|---|---|---|
| Breast Cancer Screening | X | s |
| Cervical Cancer Screening | X | s |
| Colorectal Cancer Screening | X | s |
| Diet/Nutrition | X | s |
| HPV Vaccination | X See below | s See below |
| Informed Decision Making | X | X |
| Obesity | See below | N/A |
| Physical Activity | X | s |
| Public Health Genomics | X | X |
| Sun Safety | X | s |
| Survivorship/ Supportive Care | X | X |
| Tobacco1,2,3 | X | s |
| X = Required as a primary
outcome. A minimum of one outcome ("X") must be met for the
specified program area. s = Permitted as a secondary outcome. Primary outcome requirement must be satisfied. N/A = Not Applicable. 1 - Cessation outcomes must show statistical significance for at least 6 months post-intervention, at follow-up and must demonstrate a minimum of 7-day point prevalence abstinence or continuous abstinence for the study sample, at follow-up. 2 - Prevention outcomes must show statistical significance for at least 12 months post-intervention, at follow-up. 3 - For second hand smoke exposure, one of the following primary outcomes must show statistical significance.
|
||
| Obesity1 | Outcomes | Primary Outcome | Secondary Outcome |
|---|---|---|---|
| Section 1 - Obesity behavioral outcomes | BMI | X | |
| Weight loss/Weight maintenance/Weight gain prevention2 | X | ||
| Percent body fat/lean mass/body composition | X | ||
| Reduced screen time | X | ||
| Waist circumference | X | ||
| Waist-hip ratio | X | ||
| Skin-fold thickness | X | ||
| BMI Percentile/Weight status (for children) | X | ||
| MRI of fat deposits | X | ||
| Section 2 - Obesity relevant behavioral outcomes - intervention effects can assess behavioral outcomes on diet, physical activity or both as means to monitor effects on energy balance. | Diet/Nutrition | ||
| Dietary fat intake/consumption | s | ||
| Fruit & vegetable intake/consumption | s | ||
| Serving/portion size | s | ||
| Reduced caloric intake | s | ||
| Physical Activity | |||
| Physical activity (strength or aerobic) | s | ||
| Performance on fitness tests | s | ||
| METS-Metabolic Equivalent hours, Minutes of PA | s | ||
| Reduced sedentary behavior | s | ||
| Section 3 - Obesity relevant physiological outcomes | Cardiovascular fitness | s | |
| Reduction in blood pressure | s | ||
| Lipids/HDL/LDL serum levels | s | ||
| Glycemic level (HbAlc) or measure of insulin sensitivity | s | ||
| Reduction in C-Reactive Protein | s | ||
| Sleep apnea/disruption of sleep patterns | s | ||
| Section 4 - Obesity relevant psychosocial outcomes | Depression | X | |
| Self-esteem | X | ||
| Self-efficacy | X | ||
| Body image satisfaction | X | ||
| Self-worth | X | ||
| Quality of life | X | ||
| Negative eating behaviors | X | ||
| X = Required as a primary
outcome. A minimum of one outcome ("X") from Section 1 or 4 must
be met for the Obesity program area. If there are no primary
outcomes from either Section 1 or 4, the program cannot be
considered for the Obesity program area, but may be considered for
other appropriate EBCCP program areas. If only a Section 4 outcome
is included, then the study sample must be characterized as being
overweight or obese. s = Permitted as a secondary outcome based on the following conditions: - Section 3 outcomes can be evaluated as long as 1 or more positive outcomes from Section 2 are also present in the intervention study. Section 3 outcomes cannot be considered alone. 1 - For a study to be designated as an obesity intervention, the study sample and research intent must reflect obesity characteristics. This should be evident in the main outcome publication used for EBCCP evaluation. 2 - The Intervention study from baseline assessment to follow-up needs to be at least 12 weeks when evaluating these outcomes. |
|||
| HPV Vaccination | Outcomes | Primary Outcome | Secondary Outcome |
|---|---|---|---|
| Section 1 - HPV Vaccination Behavioral and/or Psychosocial Outcomes | HPV vaccine uptake or initiation | X | |
| Increase in communication between parents and children | X | ||
| Provider communication with parents | X | ||
| Increase in schools requiring the HPV vaccine prior to enrollment | X | ||
| HPV vaccine series completion | X | ||
| Section 2 - HPV Vaccination
Cognitive Change Outcomes (i.e., changes in: knowledge, risk perception, decisional satisfaction) |
Increase in awareness and knowledge of HPV vaccine | s | |
| Change in attitude about the HPV vaccine | s | ||
| Change in beliefs about HPV vaccine | s | ||
| Intention to receive the HPV vaccination | s | ||
| X = Required as a primary
outcome. A minimum of one outcome ("X") must be met for the
specified program area. s = Permitted as a secondary outcome. Primary outcome requirement must be satisfied. |
|||
Updated:
05/11/2016